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Abstract
Purpose. In an attempt to identify clinical and histopathological factors of prognostic importance in chondrosarcomas,
115 cases of malignant and borderline chondromatous tumours were reviewed.
Patients/methods. Histopathological features tested for prognostic information as well as reproducibility included cellular-
ity, nuclear pleomorphism, multinucleated cells, mitotic activity and grade. Eleven patients had a biopsy only, and a short
survival (median 2.0 years); these were excluded from further analysis. The remaining 104 patients who had received
intended curative treatment had a median survival of 14.7 years.
Results. In univariate analysis, tumour size, extra-compartmental growth, surgical margin and sex were signi® cantly
correlated to recurrence-free survival (RFS); sex was marginally signi® cant while age, site and pathological parameters
were not signi® cant. Overall survival (OAS) was likewise found to be independent of pathological features as well as site,
size and surgical margin; but age, sex and extra-compartmental growth were statistically signi® cant. However, when the
same parameters were entered into a stepwise Cox (multivariate) analysis, only surgical margin, cellularity and pleomor-
phism were signi® cantly related to RFS; margin, grade, pleomorphism and age to OAS. Overall inter-observer agreement
on grade was relatively low: 0.54, with a Kappa value of 0.32. It was not better for the other histological parameters, with
the exception of the mitotic count. However, acceptable values were achieved when the material was divided into
low-grade (grade I and below) vs high-grade (grade II and III) lesions: overall agreement 0.79, Kappa 0.56.
Discussion. Although the grading of chondrosarcomas is in need of improvement, its replacement by semiquantitative
evaluation of individual histopathological parameters as performed in this study offers no advantage. Among the clinical
parameters, only the adequacy of the surgical treatment and the patient’s age appear to be important.
Key words: chondrosarcoma, prognosis, clinical parameters, histopathological parameters, grade, inter-observer variation.
Introduction
Chondrosarcomas follow osteosarcomas as the se-
cond most common primary malignancy of bone.
Unlike the latter, there has been no real advances in
the treatment of chondrosarcomas through the
twentieth century. The disease is remarkably resist-
ant to both radiotherapy and chemotherapy, and
surgery is still the mainstay of the treatment.
1
Since chondrosarcomas can vary in behaviour be-
tween extremely low grade, slowly growing expans-
ive lesions and highly aggressive, invasive and
metastasizing tumours, the surgeon has to balance
between the necessity to achieve an adequate surgi-
cal margin and the wish to avoid an unnecessary and
possibly disabling operation. While clinical and radi-
ological ® ndings are helpful when judging the ag-
gressiveness of the tumour, the histological grade is
often the major factor in determining the surgical
treatment. Customarily, three-grade systems are
used, with grade I indicating a slowly growing,
expansive lesion and grade III signifying a locally
aggressive tumour with a high risk of recurrence and
metastasis.
2± 4
However, the grading of chondrosarcomas is as-
sumed to be highly subjective and dif® cult even for
pathologists with experience in bone pathology.
5
This is due partly to the rarity of these tumours, and
partly to a weakness in the grading systems them-
selves. Apart from subtle differences between them,
they are also mainly descriptive, i.e. they describe
the typical grade I, II and III lesions but do not
de® ne clear boundaries between them, nor do they
explain how the individual features should be
weighted.
6,7 While this may not be a problem within
individual institutionsÐ where grading is performed
by a single pathologistÐ it does make comparison of
treatment results between the centres unreliable.
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Table 1. Histological parameters (as strati® ed in the survival analysis)
Parameter Points De® nition
Cellularity* 1 , 300 cells/mm
2
2 300± 600 cells/mm
2
3 600± 900 cells/mm
2
4 . 900 cells/mm
2
Nuclear pleomorphism** 1 Slight: uniform round/oval dark nuclei
without prominating nucleoli
2 Moderate: dark, with irregular contours
or light, round/oval with distinct
nucleoli
3 Severe: bizarre giant nuclei present
Multinucleated cells 1 , 10/mm
2
2 10± 27/mm
2
3 . 27/mm
2
Mitoses*** 0 None
1 # 1/mm
2
2 . 1/mm
2
*Extrapolated from the maximum cell density in 0.06 mm
2.
**Some compensation allowed for poor ® xation.
***Extrapolated from the count in at least 10 high power ® elds.
We therefore decided to test individual histo-
pathological parameters for reproducibility as well as
clinical relevance, together with clinical factors of
known or purported prognostic importance.
Patients and methods
Patients
The material consists of 115 patients treated for
histologically con® rmed chondrosarcomas at the
Soft Tissue and Bone Tumour Centres in Copen-
hagen and Aarhus in the period 1965± 1994. Ex-
cluded were extraskeletal, mesenchymal and
so-called dedifferentiated chondrosarcomas. In-
cluded were a few cases where the original pathol-
ogy report had given a diagnosis of borderline
chondromatous tumour (`possible chondrosar-
coma’, etc.). The following clinical parameters were
selected for analysis: age, sex, tumour site and size,
and surgical margin. Margin was classi® ed accord-
ing to Enneking.
8 The presence or absence of extra-
compartmental extension was evaluated on the
combined evidence of clinical ® ndings, radiology
and pathology. Survival was calculated from the day
of admission orÐ in the case of recurring tumours or
patients referred for other reasonsÐ from the date of
the ® rst biopsy indicating malignancy. End-points
were clinically or radiologically detected local or
distant recurrence (recurrence-free survival, RFS),
or death (overall survival, OAS).
Histological analysis
From each tumour, one or two H&E-stained slides
were selected, containing the areas that were judged
to be best preserved and diagnostic. These slides
were then circulated between three pathologists
(SD, OMJ and TS) and conventional grading was
performed following the guidelines of Gitelis et al.,
3
with knowledge of the clinical data (age, site, size).
In a second round, four individual histological
parameters (cellularity, nuclear pleomorphism,
multinucleated cells and mitotic count) were graded
and scored according to the criteria in Table 1. Area
measurements were performed with the help of ocu-
lar counting grids so that the counts could be recal-
culated per mm
2; calibration was done individually,
since the optical properties of the microscopes dif-
fered. The parameters had been selected after a
preliminary analysis which included calci® cation,
myxoid changes, cytoplasmic inclusions and growth
pattern; these were dropped from further analysis
because they gave no prognostic information in uni-
or multivariate analysis (data not shown). Invasive
growth (de® ned as demonstrable invasion in bone or
soft tissue) had shown borderline signi® cance and
was included in the present analysis, although only
as evaluated by one pathologist. For the prognostic
analysis, a consensus grade was agreed upon in all
cases with discrepancies; in the individual parame-
ters, the mean value was used.
Statistical analysis
Only patients treated with curative intent (n 5 104)
were included in the survival analysis. First, a uni-
variate analysis was performed by calculating RFS
and OAS with log-rank tests for each of the
strati® ed variables. Next, the same variables were
subjected to a multivariate analysis using Cox’s pro-
portional hazards model in a stepwise fashion, withPrognostic factors in chondrosarcomas 49
Fig. 1. Age and sex distribution of 115 patients with
chondrosarcomatous lesions. h , male; j , female.
Table 2. Location of 115 chondromatous tumours (as
strati® ed in the survival analysis)
Location n
(1) Distal 19 (hands 3, feet 4, ulna 1,
radius 1, tibia 8, ® bula 2)
(2) Proximal 33 (humerus 8, femur 25)
(3) Central 31 (pelvis/sacrum 30,
spinal column 1)
(4) Other 32 (costae 12, sternum 5,
scapula 12, clavicle 1, maxilla 2)
patients; i.e. metastases occurred altogether in only
eight of all 115 patients (7%); one had a grade I
tumour that recurred in a dedifferentiated state, four
had grade II and three had grade III tumours. Seven
of them were men, and seven were extra-compart-
mental from start, otherwise their data were unre-
markable. The OAS of the 104 patients treated with
curative intent was 0.75 at 5 years and 0.62 at 10
years (median, 14.7 years), compared with the cor-
responding rates of only 0.18 and 0 (median, 2.0
years) for the 11 patients who had a biopsy only
(p 5 0.0002, log-rank test).
Univariate analysis
The results of the log-rank tests for the individual
parameters are listed in Table 3. RFS appears to be
in¯ uenced by tumour size, extra-compartmental
growth and surgical margin. Overall survival is not
surprisingly correlated to age, but compartment is
also prognostically signi® cant. Women have a better
prognosis both with regard to RFS and OAS.
Surprisingly, conventional grade is not signi® cantly
correlated to either RFS or OAS.
Multivariate analysis
The results are listed in Table 4. For RFS, the
surgical margin is clearly the most important prog-
nostic factor, as in the univariate analysis, but cellu-
larity and pleomorphism are also statistically
signi® cant. Size and number of multinucleated cells
approach signi® cance. With regard to OAS, age and
surgical margin are the signi® cant clinical factors,
while conventional grade together with pleomor-
phism are the histopathological ones. Note that the
coef® cient for pleomorphism is negative and the
hazard ratio , 1; in other words, the more severe
the pleomorphism, the better is the prognosis.
Examples of survival curves adjusted for the
signi® cant parameters are shown in Figs 2 and 3.
Inter-observer variation
The overall agreement on grade was 0.54 with a
Kappa value of 0.32 (0.25± 0.39, 95% con® dence
all the clinical and individual histological parameters
included. p-Values, 0.05 were considered signi® -
cant; although in the stepwise Cox analysis, the
p-value for entering parameters was set to 0.05, and
for retaining them to 0.10, in order to be able to
detect possible borderline signi® cance. The
calculations were done on a computer using the
`Stata’ statistical software (Stata Corporation,
College Station, TX, USA). The inter-observer
agreement on the histopathological parameters was
evaluated by calculation of overall agreement rates
as well as the Kappa statistic.
9 Kappa is 1 if agree-
ment is total, and 0 if it is equal to the expected
chance agreement.
Results
Patients
The age and sex distribution of the 115 patients is
shown in Fig. 1. The oldest patient was a 83-year-
old man, the youngest a 4-year-old boy. The latter
was the only patient with Ollier’s disease; four pa-
tients had multiple cartilaginous exostoses. Table 2
shows the location of the tumours. Tumour sizes
varied between 1.5 and 30 cm (mean, 8.9 cm) in
largest diameter, and 54% were judged to be extra-
compartmental. Eleven patients were not treated
with curative intent, generally because of poor gen-
eral condition or inoperability (although the size of
their tumours did not differ signi® cantly from the
rest: p5 0.36, t-test). In the remaining 104 patients,
the margin was judged to be intralesional in 21,
marginal in 32, wide in 18 and radical in 32; one
was not evaluable. Their 5- and 10-year RFS was
0.62 and 0.58, respectively. A total of 31 tumours
recurred locally, one of these with concurrent lung
metastases; four recurred with metastases only. Af-
ter 8 years, no further primary recurrences occurred.
Metastases developed with later recurrences in three50 S. Daugaard et al.
Table 3. Results of univariate analysis (p-values, log-rank tests) for 104 patients treated with curative
intent
No. Parameter Strati® cation n RFS OAS
1 Age < 30 23 0.98 0.0009
31± 60 47
. 60 34
2 Sex Male 67 0.05 0.02
Female 37
3 Site Distal 19 0.44 0.28
Proximal 30
Central 25
Other 30
4 Size < 5 cm 26 0.02 0.54
5± 10 cm 41
10± 15 cm 16
. 15 cm 11
NA 10
5 Compartment Intra 47 0.01 0.01
Extra 54
NA 3
6 Margin Intralesional 21 , 0.0001 0.09
Marginal 32
Wide 18
Radical 32
NA 1
7 Invasion None 55 0.68 0.56
Present 49
8 Cellularity , 300 12 0.29 0.32
300± 600 32
600± 900 37
. 900 23
9 Pleomorphism Slight 36 0.11 0.17
Moderate 57
Severe 11
10 Multinucleated cells , 10 51 0.20 0.97
10± 27 40
. 27 13
11 Mitoses None 77 0.69 0.25
< 1 18
. 1 9
12 Grade Benign 1 0.74 0.26
Borderline 4
Grade I 35
Grade II 47
Grade III 17
NA 5 not available.
For de® nition of parameters no. 8± 11, see Table 1.
limits). Kappa values for the individual grades are
shown in Table 5. Best agreement is found for grade
III tumours, poorest for the `borderline’ category
(the negative Kappa value indicates that this diag-
nosis by one pathologist is certain to be disputed by
the others). The low values for the `benign’ category
re¯ ect the bias of sampling, since only suspectedly
or obviously malignant tumours were included; the
Kappa value will be low if the prevalence of a
diagnosis is either very low or very high in the
sample.
10 As an experiment, agreement was also
calculated after regrouping into only two categories,
low (# I) and high (II 1 III) grade; this results in an
overall agreement of 0.79 with a Kappa value of
0.56 (0.45± 0.66), which is in the acceptable range.
Table 6 shows the inter-observer agreement for
the individual histopathological variables; the Kappa
values are similar to those achieved in grading, only
mitotic activity is slightly more reproducible.
Discussion
Our results stress the overwhelming prognostic im-
portance of the surgical margin (Fig. 2), a ® nding
which is in accordance with the results of other
investigators.
2,3,11± 13 Extra-compartmental growthPrognostic factors in chondrosarcomas 51
Table 4. Results of stepwise Cox analysis
Parameter Hazard ratio (95% CI) Coef® cient (95% CI) p
RFS
Multinucleated 1.77 (0.93± 3.35) 0.57 (2 0.07± 1.21) 0.080
Size 1.43 (0.97± 2.11) 0.36 (2 0.03± 0.75) 0.073
Pleomorphism 0.35 (0.15± 0.82) 2 1.04 (2 1.88± 2 0.19) 0.017
Cellularity 1.96 (1.15± 3.34) 0.67 (0.14± 1.21) 0.014
Margin 0.41 (0.27± 0.62) 2 0.89 (2 1.3± 2 0.47) 0.000
OAS
Age 1.90 (1.16± 3.12) 0.64 (0.15± 1.14) 0.012
Pleomorphism 0.38 (0.18± 0.77) 2 0.97 (2 1.69± 2 0.26) 0.008
Grade 2.78 (1.38± 5.60) 1.02 (0.32± 1.72) 0.005
Margin 0.60 (0.43± 0.77) 2 0.51 (2 0.84± 2 0.18) 0.003
CI 5 con® dence interval.
Fig. 2. RFS (a) and OAS (b) as a function of surgical margin: 1, biopsy only; 2, intralesional; 3, marginal; 4, wide; 5, radical.
The overall survival curves have been adjusted for age and grade.
(a)
(b)
is likewise a bad omen, highly signi® cant in the
univariate test, but surprisingly not so in the
multivariate analysis± after treatment, the achieved
margin is clearly more important than local tumour
extension. The site and size of the tumours are
only marginally signi® cant; the prognostic infor-52 S. Daugaard et al.
Fig. 3. RFS (a) and OAS (b) as a function of grade: 0-grade , I; 1-grade I; 2-grade II; 3-grade III. The RFS curves have been
adjusted for surgical margin and the OAS curves for age and margin.
(b)
(a)
mation contained in these two parameters is again
surpassed by the importance of the surgical
treatment.
The importance of sex is less clear. Like Pritchard
et al.,
14 we found a better prognosis for women in
univariate analysis, but the factor lost its signi® cance
when competing with other parameters in the multi-
variate analysis.
In our material, grading had only moderate prog-
nostic value. No grade I tumours metastasized, but
grade was only statistically signi® cant with regard to
OAS in the multivariate analysis (Table 4). Only by
adjusting for surgical margin and age could the
survival curves demonstrate an increasingly poor
prognosis with increasing grade (Fig. 3). This is in
contrast to the ® ndings of other investigators who in
their univariate analyses were able to demonstrate
signi® cant correlation between grade and OAS,
although RFS appears to be poorly correlated to
grade.
2,3,12,14,15 A reason for our ® nding may be
that our grade was a compromise between three
observers; another that we may have unduly
emphasized nuclear pleomorphism (see later). How-
ever, it is worth noting that Burt et al.
11 also were
unable to demonstrate any in¯ uence of grade upon
OAS by univariate analysis of their series of 88
chondrosarcomas of the chest wall.
Of the histopathological parameters, invasion and
mitotic count were not informative, but the other
Table 5. Inter-observer agree-
ment: Kappa values on grades
Grade Kappa
Benign 0.13
Borderline 2 0.07
Grade I 0.37
Grade II 0.30
Grade III 0.48Prognostic factors in chondrosarcomas 53
Table 6. Inter-observer agreement on histopathological parameters
Parameter Overall agreement Kappa (95% CI)
Cellularity 0.52 0.34 (0.28± 0.41)
Nuclear pleomorphism 0.63 0.35 (0.27± 0.44)
Multinucleated cells 0.63 0.36 (0.28± 0.44)
Mitoses 0.77 0.45 (0.37± 0.53)
CI5 con® dence interval.
three appear to carry prognostic information, al-
though this only becomes evident in the Cox analy-
sis. Cellularity and nuclear pleomorphism seem to
be the most important factors; high cellularity
signi® es a high grade of malignancy, as would be
expected,
16 but it came as a surprise that nuclear
pleomorphism was inversely related to the prog-
nosis: the more severe the pleomorphism, the better
the prognosis. This feature was constant and could
not be explained by covariation with other variables,
and it persisted even when the 11 patients with
severe pleomorphism were left out from the analysis.
It appears to contrast with the ® nding that nuclear
area and DNA content correlate with grade
17,18 and
survival.
16 However, a high degree of nuclear
pleomorphism (as de® ned in this study) may not be
a reliable indicator of ploidy status, but could also
represent a degenerative phenomenon. Thus, nu-
clear form (as determined by the ratio long axis/
short axis) was shown not to correlate with DNA
content.
19 The cytogenetics of chondrosarcomas are
anyway complex, with no obvious relation between
chromosomal pattern and histologic grade,
20
although the number of abnormalities appears to
correlate with grade and prognosis.
21
Our inter-observer agreement on grade was rather
poor, a result which con® rms the suspicion that
conventionally performed grading of chondrosarco-
mas is highly subjective. The results are similar to
those achieved by other investigators in areas where
parameters or entities are less clearly de® ned than
generally supposedÐ for instance, some neurological
signs,
22 or subtyping and grading of pulmonary
adenocarcinomas.
23 Reducing the number of cate-
gories improves agreement, as illustrated by the
acceptable values achieved in our material by divid-
ing the lesions solely into low-grade and high-grade
lesions. This approach is debatable, however, since
it also results in loss of information.
24 In soft tissue
sarcomas, inter-observer variation in grading has
been reduced to acceptable levels by evaluating his-
tological parameters (differentiation, necrosis and
mitotic count) separately.
25 This approach appears
to be less useful as regards chondrosarcomas since
our results show the inter-observer agreement on
the individual histological parameters to be equally
poor. On the other hand, cellularity and nuclear
pleomorphism or size are features that can be esti-
mated morphometrically
18 and thereby more objec-
tively. Morphometry should therefore be
investigated as a means to reducing inter-observer
variation to manageable levels.
As mentioned earlier, DNA ploidy has been re-
ported to be a signi® cant independent prognostic
factor,
15 but determining this requires special equip-
ment and expertise in interpreting the histograms.
Other techniques such as AgNOR counting and
immunohistochemical staining for p53 or the pro-
liferation markers PCNA or Ki67 are tricky to per-
form on chondromatous tissue. They require experi-
ence and results have generally been correlated to
conventional grade, not clinical outcome.
26± 28 How-
ever, a recent report by Nawa et al.
29 indicates that
reactivity with the MIB1 antibody for Ki67 may be
a useful independent prognostic marker. Conclu-
sions are dif® cult to draw, though, because of the
rather small numbers of patients investigated in
these studies.
In conclusion, the conventional subjective grading
of chondrosarcomas is informative but less than
optimal, and improvement should be sought for
both inter-observer agreement and prognostic infor-
mation. This will probably need the introduction of
new parameters or methods in the grading pro-
cedure, but the evaluation of such new methods or
factors purported to have prognostic implication will
as a minimum require suf® cient numbers of patients
to allow strati® cation for age, treatment and grade,
best in multivariate analyses. To achieve this, it is
necessary to centralize diagnosis and treatment of
these rare tumours, and preferably to establish
multi-centre cooperation.
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